Resolution Research

Study Regarding Rare Blood Disorder

Have you ever heard of Immune (Idiopathic) Thrombocytopenic Purpura (ITP) or Chronic Immune Thrombocytopenia? Being the incidence rate is only 2 out of 100,000, the odds are you have not. ITP exists when a person has an abnormally low platelet count for unspecified reasons. This can cause abnormal bleeding throughout the body. Working in the market research industry at Resolution Research has provided a continued education after receiving my Bachelor’s degree from The University of Colorado. I have become especially well versed in the medical field, having researched numerous health conditions in order to recruit the appropriate participants. Continually having life-threatening illnesses brought to my attention has certainly provided me with an enlightened perspective on life and I am proud to be part of medical research. The current medical study Resolution Research is recruiting for involves those who currently live with ITP or Chronic Immune Thrombocytopenia. The research is being conducted by Klayman Research (http://www.naomiklayman.com/) to help a major healthcare company bring better ideas and treatments to patients who have blood disorders. If you know someone who may qualify, please spread the word and share the link to the screener (provided below). This research consists of a 60 minute phone/web interview and compensates the patient $75 for their valuable time and opinions.

Link:  http://panel2.resolutionresearch.com/survey/platelet

Exit mobile version